Score breakdown
Strengths & weaknesses
- Multi-year operating history and a broad third-party-tested catalog (while it operated as a store)
- Third-party COAs published on flagship SKUs with batch IDs
- Competitive pricing — typically below cycle median on the GLP-1 mainstream
- Wide catalog spanning research peptides + ancillary research compounds
- Customer-service responsiveness reported as inconsistent in community threads
- Mixed COA quality across the long tail — flagship SKUs are tested more rigorously than niche items
- Scored on public records only — we have placed no test order
What it sells
5 PEPTIDES WE COVERShipping & payment
FROM PUBLISHED POLICY AND USER REPORTSAudit notes
FROM THE BENCHWhat we read
For this preview profile we synthesized: approximately 90 r/Peptides comments mentioning Pure Rawz between December 2025 and April 2026; the vendor's published COAs on the GLP-1 SKUs (retatrutide, tirzepatide, semaglutide) and the healing-peptide flagships (BPC-157, TB-500); and Janoshik public-test entries where batch IDs were traceable. Nothing here comes from an order we placed; we have placed none.
Why Pure Rawz sits where it does
Pure Rawz has been operating in the US-domestic research-peptide market for several years — long enough to predate the 2025 shutdown wave. It was not one of the most-recommended vendors at the top of the market (Peptide Sciences and Amino Asylum held that position through 2024), but it was consistently named as a stable secondary option: the vendor people moved to when they wanted variety, lower prices on specific SKUs, or a backup source.
The vendor profile that emerges from public data:
- US-domestic operation: ships within the US. Domestic shipping reports cluster around 3–5 days, slightly slower than the cycle's fastest US-domestic vendors but consistent.
- COA practices: vendor publishes third-party COAs on the GLP-1 flagships and on BPC-157 / TB-500. COA discipline on the long tail (less-popular research peptides) is reported by community sources as less consistent — some SKUs have published COAs, others do not.
- Catalog breadth: covers the GLP-1 mainstream plus an unusually wide tail of ancillary research compounds. This is part of the vendor's positioning — breadth, not flagship purity.
- Pricing: positioned on the lower side of the cycle median for the GLP-1 SKUs we tracked. Roughly 5–15% below mid-tier vendors on retatrutide and tirzepatide.
Community sentiment
The dominant theme in r/Peptides comments was stability, not excellence. Pure Rawz was rarely described as the best option for any single dimension — fastest shipping, cleanest COAs, lowest prices — but it was repeatedly named as the vendor that "consistently shipped what was ordered" with "no surprises" across multi-year ordering histories.
Secondary themes included:
- Pricing as the primary draw — multiple commenters cited Pure Rawz as the price-competitive option for stacked orders
- Customer service as the primary friction — reports of slow responses (24–72 hours) on edge-case inquiries; this lowered the community-derived support subscore relative to peers
- COA depth on niche SKUs — the long-tail catalog is where community confidence drops; flagship SKUs get higher confidence
The most-cited concern was inconsistency on the long tail. Buyers ordering the GLP-1 mainstream (retatrutide, tirzepatide, semaglutide) reported a different experience than buyers ordering less-common research peptides, where COA quality and packaging discipline were described as more variable.
What a buyer can check
Public records leave these questions open. Each can be checked from the buyer's side:
- Certificate match. Before ordering, ask for the COA for the batch being shipped, and confirm the batch or lot number on the certificate matches the vial label on arrival. Look the report up on the issuing lab's own verification page rather than trusting a PDF alone.
- Long-tail SKUs. Community confidence drops on less-common compounds. Check whether the specific SKU has a published certificate at all; a GLP-1 certificate says nothing about a niche product.
- Dispatch and transit. Note the order date, the dispatch date in the tracking record, and delivery date; compare against the vendor's stated policy.
- Support response. Send a pre-sale question and time the reply; slow replies on edge-case questions are the most common community complaint.
- Endotoxin and sterility. Most published certificates cover identity and purity only. If a certificate lists no endotoxin or sterility result, that test was not done on that batch.
FAQ
Is Pure Rawz a US vendor? Yes, US-domestic with multi-year operating history under the same brand identity. Domestic transit averages 4 days.
What compounds does Pure Rawz carry? Broad catalog spanning research peptides (retatrutide, tirzepatide, semaglutide, BPC-157, TB-500) plus ancillary research compounds.
Does Pure Rawz publish lab tests? Yes. Third-party COAs are published on flagship SKUs with batch IDs. Long-tail SKUs are tested less rigorously than the mainstream. Verify test IDs at our COA verifier.
Has Pure Rawz had any regulatory action? Yes. FDA issued a warning letter to Pure Rawz (MARCS-CMS 715218, 8 September 2025, CDER) naming five tianeptine products. Separately, the storefront stopped selling in 2026 and became an affiliate/information site. We track FDA Warning Letter activity in our FDA peptide enforcement timeline.
Related
Sources
3 REFERENCES- Janoshik public-tests database — Janoshik Analytical
- Pure Rawz vendor stability ranking — The Peptide Catalog
- Janoshik 7,164-tests purity analysis — vialaudit